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Abstract 
 Antidepressants (ADs) such as fluoxetine  is known to target and 
inhibit the electron transport chain of mitochondrial, effects on rat C6 glioma 
cell function are expected. Also, it has been shown that fluoxetine can inhibit 
mitochondrial respiration in pancreatic beta cells; however whether this drug 
can also directly affect glycolytic metabolism is unknown. To address this 
idea, I have investigated effect of fluoxetine on the bioenergetics of C6 glioma. 
MTS assay was conducted as an indicator of the metabolic activity of C6 cell 
lines. Oxidative respiration was measured via oxygen consumption rate 
(OCR), anaerobic glycolysis was determined with lactate electrodes, where 
mitochondrial redox state was monitored via NAD (P) H autofluorescence. 
The metabolic assays showed glucose stimulated MTS reduction cells in a 
time and concentration dependent manner whereas, the other three 
mitochondrial fuels did not stimulated it in C6 glioma cells.  Methylpyruvate 
substrate stimulated OCR, neither both glucose and α-ketoisocaproate. 
Glucose inhibited OCR and increased lactate production compared to the 
control. Glucose failed to affect NADPH levels. Fluoxetine inhibited OCR at 
10 mM glucose. However, it did not affect OCR at 10 mM α-ketoisocaproate. 
The above results showed that C6 glioma cells are mainly depending on the 
glycolytic pathway and that was inhibited by Fluoxetine. In conclusion, since 
fluoxetine was inactive in the presence of α-ketoisocaproate our data suggest 
that the point of major action for these ADs in C6 glioma cells is glycolysis. 
 
Keywords: Fluoxetine, OCR, Lactate production, NAD(P)H, MTS , C6 
glioma rat cells 
  
Introduction 
 Glia cells compromise over half of the brain volume. They are located 
in the central and peripheral nervous system where they form Schwann cells 
in the periphery and neuralgia cells in the central nervous system. Neuroglia 
European Scientific Journal March 2018 edition Vol.14, No.9 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
13 
cells are considered as essential cells in the brain for its survival, their number 
is much more than for neurons. 
 Gliocytes have a major role in the energy supply, homeostasis, 
neurogenesis and synaptogenesis in the brain (Alvarez-Maubecin et al., 2000); 
(Srebro and Dziobek, 2001);(Kreutzberg, 1996); (Tardy et al., 1991). Early 
studies by Gee and colleagues pointed out that astrocytes are one of the most 
important type of glial cells that comprises 90% of brain and several studies 
have shown their benefits in the modulation of brain function (Gee and Keller, 
2005).They have the important role to control the extracellular such as, 
dopamine, glutamate, norepinephrine, serotonin, Acetylcholine and GABA 
(gamma-amino butyric acid) level of some ions such as K+ ions and 
neurotransmitters in the extracellular space. For instance, astrocytes express 
receptors for wide range of neurotransmitters and can liberate various kinds of 
neuroactive substrates and trophic factors. On the basis of th-7896+ese, they 
probably assist features development and function of synapses. 
 
Astrocytes 
 Astrocytes are the most abundant cell component in glial cells and 
have various supporting functions (Hu et al., 2008). They have very important 
role in metabolic interaction between astrocytes and neurons (Magistretti, 
2008a). In addition, it has been suggested that astrocytes are a valuable store 
of glycogen, such that as, when hypoglycaemia occurs, this may maintain the 
energy supply of neurones (Dienel and Cruz, 2006; Brown et al., 2004; 
Magistretti, 2008b; Vilchez et al., 2007). Glycogen may be quickly 
transformed into pyruvate or/and lactate and also metabolized via the 
tricarboxylic acid (TCA) cycle, or it could be used for biosynthesis of 
glutamate  and glucose (Hamprecht et al., 2005; Ghosh et al., 2005). It has 
been thought that the glucose and lactate produced by glia  might be 
transmitted  to neurones for fuel (Brown et al., 2004; Dringen et al., 1993), 
the so called Astrocytes, Neuron Lactate Shuttle Hypothesis 
[ANLSH](Magistretti, 2008a).  
 Proton- linked membrane transporters that carry lactate, pyruvate and 
ketone bodies through the cell membrane. Such transporters are expressed 
universally by astrocytes (Pierre and Pellerin, 2005; Rinholm et al., 2011). 
There is growing evidence confirm that the rate of glycolysis in astrocytes  is 
much higher that neurons which depends on mitochondrial respiration for their 
energy (Occhipinti et al., 2007). Furthermore, more current studies have 
addressed the critical question of which biochemical steps confirm whether 
astrocytes is rather oxidative (oxidizing both glucose and lactate) or exhibit 
some glycolytic features (by exporting rather than consuming lactate)(Neves 
et al., 2012).  
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 The onset of depression is believed to be associated with a lack of 
monoamine/ catecholamine neurotransmission in the central nervous system, 
and as a consequence therapeutic regimes mostly focus on the use of drug 
classes that are able to down-regulate or upregulate central synaptic 
monoamine/catecholamine neurotransmission. These drugs include tricyclic 
anti-depressants (TCA), monoamine oxidase inhibitors (MAOI), selective 
serotonin reuptake inhibitors (SSRI) and non-selective serotonin reuptake 
inhibitors (NSRI) as well as emerging atypical classes (McIntyre et al., 2006; 
Kiss, 2008). According to some researchers (Lustman et al., 1992; Derijks et 
al., 2008; Brown et al., 2008). 
 Indeed, it is well established that at high doses, members of the typical 
class of antidepressants, such as fluoxetine can be cytotoxic human carcinoma 
HT29 cells (Arimochi and Morita, 2006) as well as inhibiting the proliferation 
in a dose dependent manner breast cancer cells (Abdul et al., 1995). Several 
studies by (Spanová et al., 1997; Levkovitz et al., 2005) indicated that 
fluoxetine causes apoptosis in rat glioblastoma cells and human 
neuroblastoma cells. On the contrary, a study by (Mercier et al., 2004) mainly 
in vivo, found that antidepressants induce neuroprotection and facilitation of 
neural cell survival via activation in the brain of neurotrophic factors, such as 
brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF). 
Increased BDNF was found in rat hippocampus, following reboxetine and 
citalopram treatment (Russo-Neustadt et al., 2004). In addition, Several 
studies have demonstrated that fluoxetine increases the proliferation of 
B16F10 melanoma cells and C3 fibrosarcoma cells both in vivo and in vitro 
(Brandes et al., 1992) as well as fluoxetine and desipramine, a tricyclic 
antidepressant, inhibit metastasis of B16F10 lineage in young mice, but 
promote it in old mice (Kubera et al., 2009). The mechanisms that underlie 
Antidepressants neurotoxicity remain unclear. Their neurotoxicity may result 
from disruptive actions on mitochondria and oxidative respiration. For 
example, previous investigations showed that antidepressants such as 
fluoxetine especially at dosages at the higher end of their therapeutic window, 
affect the function of C6 rat glioma cells of; a phenomena that will have 
consequences for impairment of mitochondrial function of human glioma cells 
(Daley et al., 2005). However, whether this drug can also directly affect 
glycolytic metabolism is unknown. I have sought to answer this question by 
studying metabolic profile of C6 rat glioma cells. MTS reduction by using 
MTS assay, oxidative respiration was measured via oxygen consumption rate 
(OCR), anaerobic glycolysis was determined with lactate electrodes, where 
mitochondrial redox state was monitored via NAD(P)H autofluorescence. 
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Experimental procedure 
Cell lines used 
 C6 rat glioma cell lines (ATCCCRL-2199) is derived from the N-
nitrosomethylurea-induced glial rat in 1989. This cell line maintained in G418 
media for 14 days, cloned, and evaluated for beta-gal production. LacZ7 is a 
specific markers express in rat brain can be detected by histochemistry. These 
cells are adherent and when grown in the T-75 cm2 flasks, they form stable 
monolayers (Benda et al., 1968). Cell cultured medium was Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 10% (v/v) fetal calf serum, 
1% (w/v) Penicillin 1000 unit/ml- streptomycin 0.1mg/ml and 2 mM 
glutamine. Passage number used 66-100. This cell line is an astrocytic cell 




 The water-soluble salt MTS (3-[4, 5dimethylthiazol-2-yl] -5-[3-
carboxymethoxy-phenyl] -2-[4-sulfophenyl] -2H-tetrazolium) assay depends 
on reduction of the MTS substrate to produce coloured formazan. This assay 
does not need to solubilize the cells by using acidified isopropanol, which may 
disrupt the cells integrity. MTS receives electrons via an intermediate electron 
acceptor Phenazine methosulfate (PMS) which amplifies (fluorescence signal 
at 490 nM (Cory et al., 1991; Janjic and Wollheim, 1992; Segu et al., 1998). 
The MTS assay was performed according to the manufacturer's instructions 
(Celltiter 96 aqueous nonradioactive cell- proliferation assay, Promega, 
Madison, WI). The absorbance was measured at 490 nm by plate reader. 
Readings were corrected for the background by subtracting the blank 
(MTS/PMS regent in Hanks without the cells) from the readings. Three 
experiments have been performed with triplicate wells in each experiment. 
 
Oxygen Consumption Rate (OCR)  
 Mitochondrial respiratory rate of 1.1B4 and MIN6 cell suspensions 
were measured polarographically using Clark Oxygen. The partial pressure of 
O2 (PO2) was measured at a polarographic voltage of 0.6 V with electrodes 
previously calibrated at 100% air saturation (vigorous gassing with air, 
0.25mM) and 0% (addition of Na2S2O4) (Daunt et al., 2006). The background 
of Oxygen consumption by electrode was determined by the addition of 6 mM 
sodium azide to block oxidative respiration at cytochrome C. 
 
Lactate production 
 The rate of lactate production of both1.1B4 and MIN6  was measured 
polarographically with sarissa lactate enzyme electrodes (Sarissa Biomedical 
Ltd Coventry, UK) as previously mentioned by  Brown et al., 2012.  4 mL of 
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cell suspension were loaded in to a chamber, where the potential of the lactate 
electrode was set at 500 mV relative to Ag/AgCl reference electrode. 
Electrical current will be generated due to the oxidation of lactate by the lactate 
oxidase enzyme on the surface of a carbon fiber electrode. This current is a 
stoichiometric measure of lactate concentration. The lactate output rate was 
calculated according to the following equation: 
 ESubstrate (nmol 107 cell-1 min-1) = (substrate)*60/ (cells 
count)/calibration value. 
 
NAD (P) H measurements 
 NAD( P)H experiments were carried out using epifluorescence 
microscope as previously described (e.g. Duchen, 1992a,b; Duchen and 
Biscoe, 1992a,b). NAD(P)H  produced from glucose and/or amino acid 
metabolism in the mitochondria . Cells were  excited by light at 350 nm and 
measured with a bandpass fliter combination between 400 and 500 nm. To 
normalize the NAD(P)H response experiments, 10 mM glucose was used to 
reach a maximal response and this was set as a 100%. 
 
Glucose-response relationships 
 The glucose-response relationships were quantified by best fits of the 






 Where G is the concentration of glucose, EC50 is the concentration that 
Produces the half-maximal response, Y is the response magnitude, YMAX is 
the maximal response, YMIN is the minimal response, and h is an index of 




            Concentration-response relationships were constructed from multiple 
experiments using solely single concentrations. The Concentration-response 
relationships were quantified by fitting the data (without weighting) with the 
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 Where Y is the magnitude of effect as a percentage of Ymax, the 
maximum effect, [AD] is the concentration of antidepressant, EC50 is the 
concentration that produces half-maximal effect (Ymax/2) and h is an index 
of slope. Fits were performed in PRISM 6 (GraphPad Software Inc., San 
Deigo, CA). 
 
Statistical analysis  
            Data are expressed as mean ± S.E.M. Parametric statistical analysis 
was used if the data was checked to be normally distributed (D’ Agostino 
Pearson ominubus normality test). Statistical analysis was assessed in Prism 
(6.0, GraphPad software, San Diego California, USA). EC50 and h values are 




Responses to Fuels 
            There was slight increase in MTS reduction with increasing glucose 
concentration at 1 mM glucose, which saturated at 10 mM in the presence and 
absence of azide (Fig 1A). The EC50 of glucose stimulated MTS reduction was 
1.13 mM (0.9 to 1.4 95% CI) and h of 1 in the absence of azide (Fig. 1A). 
However, EC50 of glucose stimulated MTS reduction was 1.5 mM (1.4 to 2.6 
95% CI) and h of 1 in the presence of azide (Fig.1A). On the contrary, 3-MG 
(10 mmol/L), a non metabolizable analog of glucose, failed to stimulate MTS 
reduction in HIT-T15 cells (not shown). However, MP which is preferentially 
metabolized in the mitochondria of pancreatic beta cells (Segu et al., 1998) 
failed to stimulate MTS reduction compared to the vehicle control (H2O).(Fig 
1B) Both KIC and LEU (pure mitochondrial fuels) (Segu et al., 1998) did not 
stimulate MTS reduction in the presence and absence of azide (Fig.1C&D). 
Although the increments in MTS signal which found in the presence of 
glucose in contrast to MP, KIC and LEU failed to affect MTS reduction, these 
studies suggest that the predominate path is glycolytic pathway in C6 glioma 
cells. 
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Figure 1: Effects of pure mitochondrial fuels with azide (AZ) and without AZ on MTS 
reduction in C6 glioma cells: effects of glucose (A), Methylpyruvate (MP) (B), 
Ketoisocaproate (KIC) (C) Leucine (LEU) (D). Cells were incubated for 120 minute. Data 
are means ±SEM. N= 9 experiments. 
 
 Since glucose failed to increase oxygen consumption rate (OCR) in C6 
glioma cells (as shown in figure 2A), it is difficult to determine if an increased 
metabolism causes an increase OCR. Thus, we used α-ketoisocaproate (KIC) 
(Duchen et al., 1993; Gao et al., 2003; Daunt et al., 2006) and methylpyruvate 
(MP)(Jijakli et al., 1996) (Fuels that feed directly into the mitochondrial 
tricarboxylic acid cycle. MP significantly stimulated ΔO2 compared to the 
control (H2O) (P<0.01, Dunnets multicomparison test) in C6 glioma cells (Fig. 
2B). However, KIC failed to stimulate OCR compared to the vehicle control 
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Figure 2: Relationship between glucose (A), methylpyruvate (B) and α-ketoisocaproate (C) 
concentration with O2 consumption in C6 glioma cells. Data are mean and ±SEM. N= 6-10 
experiments. 
Oxygen consumption rate and Lactate output  
               Polarographic detection of O2 consumption and lactate output was 
used to measure the rate of respiration (ΔO2) and anaerobic glycolysis 
respectively. The aim of this experiment was to investigate the effect of 10mM 
glucose on the OCR and lactate production of C6 glioma cells. In the absence 
of exogenous metabolic substrate, suspensions of C6 cells consumed O2 (ΔO2) 
at linear rate commensurate with cell density at 12±1.14 nmoles 107 cells-1 
min-1. Addition of 10mM glucose inhibited ΔO2 by ~48% (p<0.05, t test) 
compared to the basal (Fig. 3A). However, in the absence of exogenous 
metabolic substrate, lactate out of C6 cells was linear rate commensurate with 
cell density at -3±6.8 nmoles 107 cells-1 min-1. 10 mM glucose caused an 
increase in the lactate output by ~%122 (p<0.05, t test) compared to basal 
condition (p<0.05, t test; Fig. 3B).  
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Figure 3: The effect of glucose 10mM on (A) Oxygen consumption rate (OCR) and (B) 
lactate production of C6 glioma. Data are mean ± SEM. N=7 experiments. 
 
NADPH autofluoresence 
 An increase in the autofluorescence signals an increase in the reduced 
state of the pyridine nucleotide NAD(P)H. Increased activity of the 
tricarboxylic acid cycle may increase substrate supply and lead to an increase 
in NAD(P)H (Duchen et al., 1993). The aim of this experiment is to support 
that the lack of an OCR with glucose is indeed due to an abnormal 
mitochondrial oxidation. Figure 4 A shows a sample trace of the action of 10 
mM glucose on the NAD(P)H levels of a single C6 glioma cell. Exposure of 
C6 glioma cells to glucose had no effect on the NAD(P)H levels compared to 
the basal (Fig.4B). 
Figure 4: Effect of 10 mM glucose on the NAD(P)H levels in the C6 glioma cells. (A) 
representative time course of 10 mM glucose on the NAD(P)H levels of a single C6 glioma 
cells monitored by the change in NAD(P)H fluorescence. (B) Before and after plot of 
NADPH fluorescence for single C6 glioma cells in response to the glucose 10 mM, the 
sugar had no effect on NAD(P)H levels compared to the basal. ). N= 19 cells collected from 
3 experiments where the minimum number of cells is 2 in each one. 
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 To further explore the metabolic pathways possibly affected by 
fluoxetine in C6 glioma  cells, other metabolic substrate that stimulates 
mitochondrial respiration via entry into different steps of the oxidation 
pathway (Duchen et al., 1993; Gao et al., 2003; Daunt et al., 2006) for glucose 
was used. 30 μM fluoxetine had no effect in the presence α-ketoisocaproate 
(Fig. 5A). However, at glucose concentration of 10 mM, 30 μM fluoxetine 
inhibited ΔO2 by ~21±12.36% (P <0.05, Dunn's multiple comparisons test) 
(Fig. 5B). 
Figure 5: The percentage effect of fluoxetine in 10 mM glucose (A) and 10 mM α-
ketoisocaproate (B) on the OCR in C6 glioma cells. Statistical significance is relative to the 
control (Cells+MTS reagent) determined via Dunnett's multiple comparisons test. Data is 
corrected for vehicle and background. The lines are all best fits of equation 1 to the data 
with IC50 given in chapter two sections 2.8. Data are the means ±S.E.M. N=5 individual 
experiments. 
 
            I repeated the same experiment by using MTS reduction in 1.1B4. Fig. 
3.8 A & B shows the curve of best fit for the fluoxetine concentration-effect 
graph in 10 mM α-ketoisocaproate and 10 mM glucose. In 10 mM α-
ketoisocaproate fluoxetine failed to affect MTS reduction (Fig. 6). In 10 mM 
glucose, there was a concentration-dependent decrease in MTS reduction with 
increasing fluoxetine concentration. The IC50 of fluoxetine inhibited MTS 
reduction was 4.4 μM (1.70 to 0.17 95% CI) and h (slope of index) of 1 (p< 
0.0001, Dunn's multiple comparisons test) (Fig. 6 ). These data are similar to 
the previous findings in MIN6 cells. This proposed that fluoxetine may inhibit 
metabolism at a step/s before the TCA cycle. In summary, these results  
explains that, a predominantly mitochondrial effect of these drugs explains 
these drugs target mitochondria which decrease redox status, as monitored by 
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the MTS assay (Elmorsy et al., 2014), appears to be the primary cause of 

















Figure 6: Concentration–effect relationships for the effect of fluoxetine in 10 mM glucose 
and 10 mM α-ketoisocaproate on the reduction of MTS in C6 glioma cells. Statistical 
significance is relative to the control (Cells+MTS reagent) determined via Dunnett's 
multiple comparisons test. Data is corrected for vehicle and background. The lines are all 
best fits of equation 1 to the data with IC50 given in chapter two sections 2.8. Data are the 
means ±S.E.M. N=4 individual experiments. 
 
Discussion 
Effect of mitochondrial fuels on the MTS reduction 
            Assessments of the metabolic activity of C6 glioma rat cells are very 
important; during the process of fuel metabolism, which are created reducing 
equivalents in the cytosolic and mitochondrial compartments C6 cells, which 
produce a measureable signal. Therefore, during static incubations of these 
cells with glucose may increase the signal derived via the reduction of MTS 
in a time and dose-dependent manner. There was a progressive increase in the 
MTS reduction with an increase in glucose concentration. The EC50 for 
glucose-stimulated MTS reduction was 1.2 mM. However, Pure mitochondrial 
fuels (KIC, MR  or LEU) failed to affect  MTS signal. These data suggest that 
the central importance of extra-mitochondrial, glycolytically derived reducing 
equivalents NAD(P)H for generation of the MTS signal (Segu et al., 1998). 
 
Metabolism 
 This is the first study to investigate the catabolic metabolism on 
oxygen consumption rate (OCR) and lactate production of C6 glioma cells. 
Basal O2 consumption of C6 glioma cells showed a linear pattern which varied 
between experiments. Figure 3A showed that basal OCR at 12 nmoles 107 
cells-1 min-1 of C6 glioma cells. Earlier studies confirm that basal levels of 
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Oxygen consumption rate were roughly 20 nmol 107 cells-1 min-1  in pancreatic 
beta cell lines (MIN6) (Daunt et al., 2006). Difference in the basal respiration 
may be due to the presence of fatty acids in the cells suspensions (Lopaschuk 
et al., 2010) . Figure 3B showed that basal lactate production at -3 nmoles 107 
cells-1 min-1 C6 glioma cells. This suggests that the differences may be due to 
drift in the lactate electrode. No previous data had been reported for lactate 
output in C6 glioma cells. The 1-fold inhibition in the rate of OCR produced 
by 10 mM glucose for C6 glioma cells accompanied by 6-fold stimulation in 
the lactate production for C6 glioma cells. This suggests the adding of glucose 
was either metabolized solely by glycolysis and apparently not by the TCA, 
or the cells have marginal oxidative capacity (WARBURG, 1956). This may 
lead to inhibit of oxidative respiration by glycolytic products Crabtree effect 
(Diaz-Ruiz et al., 2011). 
 
NAD(P)H levels 
 The measurement of the endogenous fluorescent compound NAD(P)H 
serves as an indicator of glucose-induced changes of the  energy metabolism 
(Panten et al., 1973; Duchen et al., 1993; Martens et al., 2005; Ghaly et al., 
2014). As NAD(P)H autofluoresence  results  mainly from the mitochondria 
(Pralong et al., 1990; Patterson et al., 2000; Luciani et al., 2006; De Marchi et 
al., 2014; Ghaly et al., 2014). An increase in the fluorescence signals an 
increase in the reduced state of the pyridine nucleotide NAD(P)H. Thus, an 
increased activity of the tricarboxylic acid cycle in response to increased 
substrate supply should lead to an increase in NAD(P)H (Duchen et al., 1993), 
The results denote that 10 mM glucose  did not stimulate NAD(P)H levels. 
This suggests that the glucose was metabolized solely by glycolysis, and not 
by the TCA, glucose significantly increased the lactate output with decrease 
of NAD(P)H levels. 
 
Fluoxetine effect the glycolytic pathway of C6 glioma cells 
 In order to investigate whether the fluoxetine acts on the glycolytic 
pathway, my findings have reported that fluoxetine does not cause any effect 
on the OCR and MTS reduction whereas, it inhibited the OCR in 10 mM 
glucose in C6 glioma cells. This suggests that fluoxetine may inhibit 
metabolism at a step/s before the TCA cycle. How does the concentration of 
glucose affect fluoxetine’s action as shown in the Fig. 5,6. Addition of glucose 
may affect the pH of the cytosol. For example, the presence of glucose may 
change the cytosolic pH to be more acidic as a result of high rate of glycolysis 
in 1.1B4 cells; this in turn will attract the antidepressants such as fluoxetine 
which may have ionisation constants (pKa's) >7.4 leading to accumulate this 
drug in the cytosol (Lombardo et al., 2004). 
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Conclusion   
 Our results suggest that the glycolytic pathway is the predominate path 
for glucose utilization in the C6 glioma cell model. Since fluoxetine was 
inactive in the presence of α-ketoisocaproate our data suggest that the point of 
major action for these ADs in glioma cells is glycolysis.  
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